Prasad's tenure was generally marked by controversy, but he is departing amid a cluster of self-destructive decisions. Those include a shocking rejection of an mRNA vaccine (which was over the objections of agency scientists and quickly reversed); a demand for an additional clinical trial on a gene therapy for Huntington's disease, which was widely seen as moving the goalpost for the therapy; his startling choice to publicly attack the maker of that gene therapy, UniQure; and alleged abuse of FDA staff, who say he created a toxic work environment.
a:focus:focus-visible {
，更多细节参见新收录的资料
但对于魔法原子而言，失去了技术灵魂人物的公司，能否在保持产品定义敏锐度的同时，加速填平出货量与声量之间的鸿沟，将决定它能否在接下来这轮行业洗牌中留在牌桌上。
第一百八十一条 本章下列用语的含义：
第一个原因是找不到权限和风险之间的平衡点。